Atlas Trials

Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis

Clinical trial NCT07052981 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07052981
Sponsor
Guixia Ding
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
IgA Nephropathy (IgAN)IgAVN
Start date
2025-08-01
Primary completion
2027-06-30
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.